Gene · 104
Papers2,137
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,137
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genomic Landscape and Potential Regulation of RNA Editing in Drug Resistance. | Adv Sci (Weinh) | 2023 | 36912579 | PubTator, text mining | PubMed |
| Autocatalytic base editing for RNA-responsive translational control. | Nat Commun | 2023 | 36906659 | PubTator, text mining | PubMed |
| Dominant Gene Expression Profiles Define Adenoid Cystic Carcinoma (ACC) from Different Tissues: Validation of a Gene Signature Classifier for Poor Survival in Salivary Gland ACC. | Cancers (Basel) | 2023 | 36900183 | PubTator, text mining | PubMed |
| Genome-wide identification of A-to-I RNA editing events provides the functional implications in PDAC. | Front Oncol | 2023 | 36895481 | PubTator, text mining | PubMed |
| Identification of exceptionally potent adenosine deaminases RNA editors from high body temperature organisms. | PLoS Genet | 2023 | 36877730 | PubTator, text mining | PubMed |
| A novel RNA modification prognostic signature for predicting the characteristics of the tumor microenvironment in gastric cancer. | Front Oncol | 2023 | 36874129 | PubTator, text mining | PubMed |
| The Dynamic Linkage between Provirus Integration Sites and the Host Functional Genome Property Alongside HIV-1 Infections Associated with Antiretroviral Therapy. | Vaccines (Basel) | 2023 | 36851277 | PubTator, text mining | PubMed |
| Development of a selection assay for small guide RNAs that drive efficient site-directed RNA editing. | Nucleic Acids Res | 2023 | 36840708 | PubTator, text mining | PubMed |
| Genome-Wide Gene-Set Analysis Identifies Molecular Mechanisms Associated with ALS. | Int J Mol Sci | 2023 | 36835433 | PubTator, text mining | PubMed |
| ERβ1 Sensitizes and ERβ2 Desensitizes ERα-Positive Breast Cancer Cells to the Inhibitory Effects of Tamoxifen, Fulvestrant and Their Combination with All-Trans Retinoic Acid. | Int J Mol Sci | 2023 | 36835157 | PubTator, text mining | PubMed |
| RNA Helicase DDX6 Regulates A-to-I Editing and Neuronal Differentiation in Human Cells. | Int J Mol Sci | 2023 | 36834609 | PubTator, text mining | PubMed |
| Understanding the Epitranscriptome for Avant-Garde Brain Tumour Diagnostics. | Cancers (Basel) | 2023 | 36831575 | PubTator, text mining | PubMed |
| Antitumor Potential of Antiepileptic Drugs in Human Glioblastoma: Pharmacological Targets and Clinical Benefits. | Biomedicines | 2023 | 36831117 | PubTator, text mining | PubMed |
| Transcription-wide impact by RESCUE-induced off-target single-nucleotide variants in mammalian cells. | J Mol Cell Biol | 2023 | 36822625 | PubTator, text mining | PubMed |
| Cognitive impairments in a Down syndrome model with abnormal hippocampal and prefrontal dynamics and cytoarchitecture. | iScience | 2023 | 36818290 | PubTator, text mining | PubMed |
| The Impaired Wound Healing Process Is a Major Factor in Remodeling of the Corneal Epithelium in Adult and Adolescent Patients With Keratoconus. | Invest Ophthalmol Vis Sci | 2023 | 36811882 | PubTator, text mining | PubMed |
| Reversal of malignant ADAR1 splice isoform switching with Rebecsinib. | Cell Stem Cell | 2023 | 36803553 | PubTator, text mining | PubMed |
| Core-binding factor fusion downregulation of ADAR2 RNA editing contributes to AML leukemogenesis. | Blood | 2023 | 36796022 | PubTator, text mining | PubMed |
| On the origin and evolution of RNA editing in metazoans. | Cell Rep | 2023 | 36795564 | PubTator, text mining | PubMed |
| Therapeutic strategies for autism: targeting three levels of the central dogma of molecular biology. | Transl Psychiatry | 2023 | 36792602 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/104/papers?page=14